KPWS
BIO icon

Kestra Private Wealth Services’s Bio-Rad Laboratories Class A BIO Stock Holding History

Kestra Private Wealth Services’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-946
Closed -$395K – 911
2022
Q3 		$395K Buy
946
+137
+17% +$68.3K 0.02% 562
2022
Q2 		$400K Buy
809
+25
+3% +$13K 0.02% 572
2022
Q1 		$442K Sell
784
-326
-29% -$197K 0.02% 619
2021
Q4 		$839K Buy
1,110
+605
+120% +$453K 0.04% 436
2021
Q3 		$377K Buy
+505
New +$378K 0.02% 624

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Kestra Private Wealth Services's BIO Position: Q4 2022 in Review

Kestra Private Wealth Services sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2022, closing a stake of 946 shares — an estimated $395K sold.

Kestra Private Wealth Services first reported a position in BIO in Q3 2021 and held it in 5 quarters. The position peaked at $839K in Q4 2021. 470 funds tracked by Wall St. Rank hold BIO as of Q4 2022.

  • Kestra Private Wealth Services reported no remaining Bio-Rad Laboratories Class A position as of Q4 2022 after selling out during the quarter.
  • Kestra Private Wealth Services sold 946 Bio-Rad Laboratories Class A shares in Q4 2022, an estimated $395K.
  • Kestra Private Wealth Services first reported a position in Bio-Rad Laboratories Class A in Q3 2021 and held it in 5 quarters.
  • Kestra Private Wealth Services's Bio-Rad Laboratories Class A position peaked at $839K in Q4 2021.
  • 470 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2022.

Based on Kestra Private Wealth Services's 13F filing for Q4 2022, filed 1 Feb 2023.